ABSTRACT
The hematopoietic system is continually renewed from hematopoietic stem cells (HSCs) and progenitor cells (1) . To isolate HSCs and other progenitor cells, a variety of purification strategies have been developed. Most commonly, cells have been fractionated based on the expression of cell surface markers such as Sca-1, thy-1, CD34, CD38, HLA-DR, and c-kit (2) (3) (4) (5) (6) (7) (8) . Fractionations based on size and cell density, efflux of metabolic dyes, or resistance to cytotoxic agents also have been used (9) (10) (11) (12) (13) (14) . Although these strategies have been useful for studying hematopoiesis and for some clinical applications, they suffer from several drawbacks. Many of the HSC characteristics have been found to vary between species, genetic background, or stem cell source (1, 15) . Cell populations that have been isolated based on many of these criteria have been heterogeneous, with significant overlap between HSCs and more mature progenitors (16) . In addition, the phenotype of cultured or transplanted stem cells may remain stable despite a decline in functional activity (17, 18) . Populations with the phenotypic characteristics of HSCs have been isolated that are not able to reconstitute hematopoiesis (19) . CD34 and other markers may be found only on some, but not all, HSCs (5, (20) (21) (22) . Finally, many of the stem cell isolation procedures described to date involve the use of multiple steps, reagents, and costly procedures that do not lend themselves to clinical applications.
Because of these issues, we have been searching for simpler and more reliable methods for isolating primitive human hematopoietic cells. One potential strategy is to develop a fluorescent substrate for an enzyme that is expressed at relatively high levels in stem cells compared with more differentiated cells. Fluorescence-activated cell sorting (FACS) then could be used to isolate the brightest staining cells. One candidate enzyme for such a strategy is aldehyde dehydrogenase (ALDH) (23) . ALDH is a cytosolic enzyme that is responsible for oxidizing a variety of aldehydes including vitamin A (24, 25) . ALDH is expressed at high levels in hematopoietic progenitors and appears to be responsible for the resistance of HSCs to the alkylating agents cyclophosphamide and 4-hydroxyperoxycyclophosphamide (10, (26) (27) (28) . Jones et al. (22, 29) demonstrated proof of the principle for this strategy in the murine system. They showed that mouse HSCs could be isolated by staining partially purified bone marrow stem cells with a fluorescent substrate for ALDH, termed dansyl-aminoacetaldehyde (DAAA), and then selecting cells with the highest fluorescence intensity. Although provocative, this approach suffers from several drawbacks. To yield highly purified stem cells, it appeared necessary to combine DAAA staining with several other fractionation steps. In addition, DAAA fluorescence is excited by UV light, which could be mutagenic to cells. The emission spectra of DAAA overlaps with that of other fluorochromes so that DAAA staining cannot be readily combined with other stem cell markers. Last, this method has not been shown to be useful for isolating primitive human HSCs.
Because of these limitations, we designed a fluorescent substrate for ALDH, termed BODIPY aminoacetaldehyde (BAAA), that consists of an aminoacetaldehyde moiety bonded to the BODIPY fluorochrome. We report here that staining with BAAA provides a simple and efficient strategy for isolating primitive human hematopoietic cells. Synthesis and Preparation of BAAA. Using an amber vial, a solution of aminoacetaldehyde diethyl acetal (AAA-DA, 19 mol, 2.8 l, Aldrich) in dry tetrahydrofuran (THF, 0.1 ml) was added dropwise to a solution of 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-proprionic acid, succinimidyl ester (BODIPY FL,SE) (13 mol, 5 mg, Molecular Probes D-2184) in dry THF (0.5 ml). Upon complete addition, the vial was capped and the reaction mixture was stirred (30 min) in the dark. The THF was evaporated, the residue was dissolved in minimal methylene chloride and then filtered through a pipette filled with silica gel (230-400 mesh) by using ethyl acetate͞hexane (1:1) as eluent. The product (R f 0.26), BODIPY-aminoacetaldehyde diethyl acetal (BAAA-DA) ( Fig. 1 Antibody Reagents. Directly conjugated fluorescent antibodies directed against the following antigens were used: CD14 [Leu-M3; phycoerythrin (PE) and allophycocyanin (APC)], CD34 (HPCA2; PE and APC), CD38 (Leu-17; PE and APC), CD56 (neural cell adhesion molecule 16.2; PE), CD20 (Leu-16; PE), CD3 (Leu-4; PE) all from Becton Dickinson Immunocytometry Systems; CD7 (3A1, Coulter), and CD19 (J4.119, Immunotech, Westbrook, ME).
MATERIALS AND METHODS

Cell
Cell Staining and FACS. All cells were stained at densities of 10 6 cells͞ml in Iscove's modified Dulbecco's medium with 2% FCS (staining medium). Based on preliminary titration experiments, cell lines were labeled with 20 M BAAA, and mononuclear UCB cells were labeled with 1 M BAAA for 30 min. To inhibit multidrug-resistance activity, verapamil (American Regent Laboratories, Shirley, NY) was included at a final concentration of 50 M. For multiparameter FACS, additional antibody reagents were added directly to cell suspensions at 10 7 cells͞ml in staining medium. To exclude dying cells, 7-aminoactinomycin D (Molecular Probes) was added at a final concentration of 10 g͞ml. Cells were incubated on ice for 20 min and then washed in ice-cold staining media. The cells then were analyzed on a FACSCalibur instrument equipped with 488-nM argon lasers (Becton Dickinson Immunocytometry Systems) or sorted on a FACStarPLUS cell sorter equipped with dual 488-nM Coherent I-90 lasers and an argon-dye laser for APC excitation (Becton Dickinson Immunocytometry Systems). The BODIPY moiety was excited at 488 nm, and its fluorescence was detected by using a standard FITC 530͞30 bandpass filter.
Hematopoietic Progenitor Colony Assays (HPCAs) and Long-Term Cultures (LTCs). UCB cells were stained with BAAA, verapamil, and anti-CD14 as described above, and Fig. 3 . Anti-CD14 was included in these experiments to exclude monocytes that contaminated the SSC lo ALDH br cell-sorting gate. HPCAs were performed by plating 100-200 cells in MethoCult GF H4434 containing recombinant human kit ligand, IL-3, granulocyte͞macrophage colony-stimulating factor, and erythropoietin (StemCell Technologies, Vancouver). The cells were incubated in a humidified chamber at 37°C with 5% CO 2 , and then hematopoietic colonies (Ͼ100 cells) were scored after 18 days. LTCs were maintained on murine MS-5 stromal cells (graciously provided by Tadashi Sudo, Kirin Pharmaceutical Research Laboratory, Gunma, Japan) (31). MS-5 stromal cells were seeded into 24-well plates (Corning) at 5 ϫ 10 4 cells͞well in MEM␣͞10% FCS and cultured at 37°C in 5% CO 2 . When the monolayers approached 80% confluence they were ␥-irradiated from a cesium source (40 Gy). For LTCs, the culture media were replaced entirely with MEM␣͞10% FCS͞10% equine serum͞ 5 ϫ 10 Ϫ5 M ␤-mercaptoethanol͞1 mM pyruvate. LTCs were initiated with 500-2,000 hematopoietic progenitor cells͞well and were maintained at 33°C in 5% CO 2 . At weekly intervals, half the media from each well were removed and replaced with fresh media. Adherent and nonadherent cells were harvested after 5 or 8 weeks and were plated into HPCAs as described above. LTC activity was defined as the number of HPCAs developing after 5-8 weeks in stromal LTCs per 1,000 cells used to establish the cultures.
Statistics. Statistical analysis was performed by using the paired two-tailed Student's t test.
RESULTS
BAAA Is a Substrate for ALDH.
To develop a fluorescent substrate for ALDH, the fluorescent compound BODIPY FL,SE was reacted with AAA-DA to yield the stable compound BAAA-DA (Fig. 1) . Immediately before cell staining, this compound was converted to the more labile ALDH (Fig. 1) . Consequently, cells expressing high levels of ALDH could be identified based on their bright fluorescence intensity. To test this hypothesis, murine L1210 cells and a cyclophosphamide-resistant derivative termed L1210͞cpa were stained with BAAA and examined by flow cytometry (Fig. 2 ). L1210 cells express low levels of ALDH whereas the L1210͞cpa cells express high levels of ALDH (30) . Consistent with this, the L1210 cells exhibited dim staining with BAAA ( Fig. 2 A) , whereas the L1210͞cpa cells stained brightly with BAAA (Fig. 2B) . In both lines, staining with BAAA was significantly inhibited by a 10-fold molar excess of diethylaminobenzaldehyde (DEAB), a specific inhibitor of ALDH ( Fig. 2 A and B) (32) . To test whether BAAA was a substrate for human ALDH, K562 cells were stained with BAAA (28, 33) . K562 cells stained moderately with BAAA ( Fig. 2C) , and the staining was inhibited by DEAB (Fig. 2C) , confirming that BAAA is a substrate for both murine and human ALDH. Cells Are Present in Human UCB That Stain Brightly With BAAA. To determine whether BAAA could stain primary human hematopoietic cells, red cell-depleted UCB mononuclear cells were treated with BAAA and analyzed. UCB was chosen for these studies because of its increasing promise as a source of transplantable HSCs (34) . An optimal concentration of 1 M BAAA was found to best discriminate ALDH br cells from more dimly staining populations (data not shown and Fig.  3 A and B) . Staining was inhibited by DEAB, confirming that the fluorescence emission of the BAAA-stained UCB was the result of ALDH activity (Fig. 3B) . The BAAA-stained UCB exhibited two distinct peaks of fluorescence emission (Fig. 3B) . The brighter fluorescence emission peak was nearly entirely caused by monocytes (Fig. 3C and data not shown) . Because the BODIPY fluorescence from monocytes obscured the signal from hematopoietic progenitor cells, the BAA signal was examined only in cells with low orthogonal light scattering (SSC lo cells, defined by gate R1 in Fig. 3A ) in all subsequent studies (35) . In addition, because in preliminary experiments we found that BAA was a substrate for the high level of multidrug-resistance (MDR) efflux activity in primitive hematopoietic cells (data not shown), MDR was blocked with verapamil during the staining procedure to enhance the discrimination of primitive cells (36) . With this approach, a small, but clearly defined, subpopulation of SSC lo cells stained brightly with BAAA (SSC lo ALDH br cells, defined by region M1 in Fig. 3D) . UCB was costained with BAAA, verapamil, and antibodies to various lineage commitment antibodies, and the content of each subset then was enumerated in the total UCB and the SSC lo ALDH br gate (defined in Fig. 3 A and D) . The data are the mean Ϯ SD of 2-4 experiments.
Cell Biology: Storms et al.
Proc. Natl. Acad. Sci. USA 96 (1999) relatively mature myeloerythroid progenitors whereas the 5-week and 8-week LTC assays enumerate progressively more primitive progenitors (37 (Fig. 5 A and B) . In contrast, the SSC lo ALDH br population was significantly more enriched in 8-week LTC activity (140-fold) than the CD34 ϩ population (85-fold) (P Ͻ 0.05, n ϭ 6, Fig. 5C ) relative to unfractionated UCB. In summary, the phenotypic and functional assays demonstrate that the SSC lo ALDH br population is highly enriched for primitive hematopoietic cells.
DISCUSSION
In this report we describe the development of a fluorescent reagent, BAAA, which is a substrate for ALDH in both murine and human cell lines. There are several potential advantages to using BAAA staining for isolating primitive human hematopoietic cells compared with currently available methods. The BAAA staining method is simple and inexpensive and does not require large amounts of mAbs. In addition, BAA should not enter the nucleus or bind DNA, the fluorchrome is excited by visible light, and BAA appears to be rapidly effluxed once verapamil is removed (data not shown). Consequently, isolating primitive cells with BAAA staining may be safer and less toxic than methods based on staining with dyes that bind to nucleic acids or require UV excitation (20) . Another advantage of BAAA staining is that the emission spectrum of BAA does not overlap significantly with other fluorochromes so that BAAA staining can be readily combined with additional markers. Last, because high-level expression of ALDH appears to be an intrinsic property of a variety of stem cells, isolating primitive hematopoietic cells on the basis of ALDH activity may not be affected as significantly by the stem cell source, genetic background, or stem cell manipulation as other stem cell isolation methods (23) . Future preclinical studies, including transplantation into immunodeficient mice, as well as clinical trials will help determine whether staining for ALDH activity FIG. 5 . SSC lo ALDH br UCB is enriched in hematopoietic progenitors. Unfractionated, CD34 ϩ , and SSC lo ALDH br UCB cells were isolated and placed into HPCA (A), 5-week LTC (B), and 8-week LTC (C) assays. As described in Materials and Methods, CD14 ϩ cells also were removed during the isolation of the SSC lo ALDH br population because these cells were the major contaminant in preliminary sorting experiments. The bar graphs demonstrate the mean (ϮSD) of six experiments. The difference in HPCA, 5-week LTC, and 8-week LTC was significantly different (P Ͻ 0.05) between unfractionated UCB and both the CD34 ϩ and SSC lo ALDH br populations. In addition, the proportion of 8-week LTCs was significantly higher (P Ͻ 0.05) in the SSC lo ALDH br population compared with the CD34 ϩ population whereas no differences were noted between the HPCA and 5-week LTC proportions.
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Cell Biology: Storms et al. Proc. Natl. Acad. Sci. USA 96 (1999) is superior to other methods for isolating primitive hematopoietic cells (38) . There are several potential applications to this strategy for identifying and isolating HSCs. Enumerating SSC lo ALDH br cells may be a more reliable means for quantitating the transplantable stem cells in bone marrow, peripheral blood, and UCB (39) . Isolating SSC lo ALDH br cells also may be an effective method for purging autologous bone marrow or peripheral blood stem cell collections of tumor cells (23, 40) . This method could replace the use of 4-hydroxyperoxycyclophosphamide for tumor purging because it results in less nonspecific cell toxicity and can be adjusted during the stem cell isolation procedure. Because T cells appear to be depleted during the isolation of SSC lo ALDH br cells, the BAAA staining method may effectively remove the T cells capable of causing graft versus host disease in allogeneic transplant applications. This method also may be useful for evaluating tumor samples to determine whether they are resistant to cyclophosphamide and other oxazaphosphorines. Last, because ALDH is expressed in a wide variety of stem cells, the BAAA staining method may have broad applicability to isolating stem cells such as embryonic stem cells or gut stem cells for analytical and clinical purposes (23, 41) .
